Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypotension, Orthostatic | 11 | 2019 | 55 | 5.09 | Why? |
| Accidental Falls | 12 | 2019 | 448 | 4.72 | Why? |
| Ireland | 44 | 2019 | 1456 | 3.23 | Why? |
| Syncope | 9 | 2019 | 238 | 2.90 | Why? |
| Aging | 26 | 2021 | 3581 | 2.61 | Why? |
| Independent Living | 16 | 2019 | 842 | 2.11 | Why? |
| Vitamin D Deficiency | 9 | 2021 | 1782 | 1.83 | Why? |
| Gait | 5 | 2019 | 137 | 1.80 | Why? |
| Mobility Limitation | 3 | 2017 | 153 | 1.72 | Why? |
| Longitudinal Studies | 41 | 2021 | 9893 | 1.59 | Why? |
| Cognition Disorders | 6 | 2018 | 574 | 1.40 | Why? |
| Cognition | 6 | 2018 | 1394 | 1.30 | Why? |
| Walking Speed | 4 | 2019 | 77 | 1.26 | Why? |
| Geriatric Assessment | 9 | 2019 | 1372 | 1.18 | Why? |
| Vitamin D | 9 | 2021 | 2904 | 1.16 | Why? |
| Lutein | 3 | 2017 | 5 | 1.09 | Why? |
| Zeaxanthins | 3 | 2017 | 5 | 1.09 | Why? |
| Heart Rate | 7 | 2021 | 1527 | 1.09 | Why? |
| Blood Pressure | 10 | 2021 | 2198 | 1.07 | Why? |
| Posture | 3 | 2017 | 199 | 0.91 | Why? |
| Disability Evaluation | 2 | 2017 | 671 | 0.90 | Why? |
| Macular Degeneration | 4 | 2018 | 194 | 0.88 | Why? |
| Blood Pressure Determination | 5 | 2018 | 450 | 0.80 | Why? |
| Cognitive Aging | 1 | 2018 | 12 | 0.75 | Why? |
| Depressive Disorder | 3 | 2018 | 1236 | 0.73 | Why? |
| Electrodes, Implanted | 1 | 2016 | 60 | 0.61 | Why? |
| Frail Elderly | 2 | 2018 | 1427 | 0.60 | Why? |
| Depression | 9 | 2021 | 14116 | 0.59 | Why? |
| Hypercholesterolemia | 1 | 2017 | 175 | 0.58 | Why? |
| Linear Models | 6 | 2021 | 1914 | 0.52 | Why? |
| Anesthesia, General | 1 | 2018 | 470 | 0.51 | Why? |
| Visual Acuity | 2 | 2017 | 790 | 0.49 | Why? |
| Surgical Procedures, Operative | 2 | 2018 | 2662 | 0.47 | Why? |
| Fear | 2 | 2017 | 3607 | 0.47 | Why? |
| Multivariate Analysis | 8 | 2019 | 5440 | 0.46 | Why? |
| Logistic Models | 11 | 2021 | 9089 | 0.46 | Why? |
| Psychomotor Performance | 1 | 2012 | 110 | 0.46 | Why? |
| Aged | 60 | 2021 | 215776 | 0.45 | Why? |
| Aged, 80 and over | 35 | 2021 | 88759 | 0.44 | Why? |
| Risk Factors | 26 | 2021 | 71621 | 0.41 | Why? |
| Middle Aged | 53 | 2021 | 270681 | 0.40 | Why? |
| Child Abuse | 1 | 2017 | 504 | 0.39 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.39 | Why? |
| Disabled Persons | 2 | 2017 | 1152 | 0.39 | Why? |
| Autonomic Nervous System | 3 | 2021 | 148 | 0.38 | Why? |
| Cystatin C | 3 | 2018 | 125 | 0.36 | Why? |
| Male | 61 | 2021 | 367725 | 0.36 | Why? |
| Age Factors | 14 | 2021 | 21039 | 0.35 | Why? |
| Prevalence | 15 | 2021 | 25773 | 0.35 | Why? |
| Female | 61 | 2021 | 380317 | 0.35 | Why? |
| Executive Function | 3 | 2018 | 173 | 0.35 | Why? |
| Dietary Supplements | 5 | 2021 | 2251 | 0.34 | Why? |
| Odds Ratio | 6 | 2017 | 5861 | 0.33 | Why? |
| Glomerular Filtration Rate | 3 | 2018 | 1262 | 0.33 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.32 | Why? |
| Health Surveys | 2 | 2017 | 2841 | 0.31 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.31 | Why? |
| Electrocardiography, Ambulatory | 2 | 2016 | 204 | 0.30 | Why? |
| Atrial Fibrillation | 2 | 2017 | 2320 | 0.27 | Why? |
| Cohort Studies | 12 | 2019 | 36005 | 0.27 | Why? |
| Phenotype | 1 | 2015 | 4037 | 0.27 | Why? |
| Apolipoproteins E | 1 | 2005 | 170 | 0.27 | Why? |
| Cognitive Dysfunction | 5 | 2018 | 1389 | 0.27 | Why? |
| Humans | 77 | 2021 | 930598 | 0.27 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.27 | Why? |
| Fatigue | 3 | 2021 | 2479 | 0.26 | Why? |
| Inflammatory Bowel Diseases | 1 | 2020 | 3209 | 0.24 | Why? |
| Chi-Square Distribution | 4 | 2017 | 961 | 0.24 | Why? |
| Brain | 2 | 2018 | 5133 | 0.24 | Why? |
| Prospective Studies | 14 | 2019 | 43301 | 0.23 | Why? |
| Arrhythmias, Cardiac | 1 | 2016 | 2510 | 0.23 | Why? |
| Time Factors | 10 | 2021 | 31397 | 0.23 | Why? |
| Hypertension | 3 | 2018 | 8895 | 0.23 | Why? |
| Guideline Adherence | 2 | 2017 | 2309 | 0.23 | Why? |
| Rickets | 1 | 2021 | 11 | 0.23 | Why? |
| Regression Analysis | 4 | 2021 | 2484 | 0.22 | Why? |
| 25-Hydroxyvitamin D 2 | 1 | 2020 | 28 | 0.22 | Why? |
| Clinical Trials as Topic | 2 | 2017 | 7330 | 0.21 | Why? |
| Syncope, Vasovagal | 1 | 2019 | 16 | 0.20 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2019 | 49 | 0.19 | Why? |
| Nifedipine | 1 | 2018 | 27 | 0.19 | Why? |
| Nootropic Agents | 1 | 2018 | 23 | 0.19 | Why? |
| Folic Acid Deficiency | 1 | 2018 | 22 | 0.19 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.19 | Why? |
| Loneliness | 2 | 2021 | 1766 | 0.18 | Why? |
| Plethysmography | 1 | 2018 | 30 | 0.18 | Why? |
| Contrast Sensitivity | 1 | 2017 | 8 | 0.18 | Why? |
| Cross-Sectional Studies | 14 | 2018 | 53120 | 0.18 | Why? |
| Polypharmacy | 2 | 2019 | 347 | 0.18 | Why? |
| Vitamin B 12 Deficiency | 1 | 2018 | 57 | 0.18 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.17 | Why? |
| Inappropriate Prescribing | 2 | 2018 | 284 | 0.17 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2018 | 137 | 0.17 | Why? |
| Alzheimer Disease | 2 | 2018 | 1020 | 0.17 | Why? |
| Self Report | 3 | 2018 | 3802 | 0.17 | Why? |
| Hospitalization | 3 | 2018 | 54280 | 0.17 | Why? |
| Memory | 1 | 2018 | 137 | 0.17 | Why? |
| Vitamin B 12 | 1 | 2018 | 132 | 0.16 | Why? |
| Macula Lutea | 1 | 2017 | 87 | 0.16 | Why? |
| Longevity | 1 | 2018 | 159 | 0.16 | Why? |
| Gait Disorders, Neurologic | 1 | 2017 | 64 | 0.16 | Why? |
| Folic Acid | 1 | 2018 | 172 | 0.16 | Why? |
| Carotenoids | 1 | 2017 | 70 | 0.16 | Why? |
| Medical Futility | 1 | 2017 | 150 | 0.16 | Why? |
| Electrocardiography | 3 | 2021 | 3957 | 0.16 | Why? |
| Spirituality | 1 | 2019 | 228 | 0.16 | Why? |
| Postural Balance | 1 | 2017 | 144 | 0.16 | Why? |
| Population Surveillance | 3 | 2018 | 4967 | 0.16 | Why? |
| Lipoproteins, LDL | 1 | 2017 | 115 | 0.16 | Why? |
| tau Proteins | 1 | 2016 | 162 | 0.15 | Why? |
| Resuscitation Orders | 1 | 2017 | 188 | 0.15 | Why? |
| Cerebral Cortex | 1 | 2018 | 276 | 0.15 | Why? |
| Attention | 2 | 2017 | 335 | 0.15 | Why? |
| Gray Matter | 1 | 2017 | 150 | 0.15 | Why? |
| Motor Activity | 1 | 2017 | 217 | 0.15 | Why? |
| Incidence | 7 | 2019 | 25622 | 0.15 | Why? |
| Health Status | 3 | 2018 | 3259 | 0.15 | Why? |
| Religion | 1 | 2019 | 353 | 0.15 | Why? |
| Blood Pressure Monitoring, Ambulatory | 2 | 2017 | 341 | 0.15 | Why? |
| Anxiety | 2 | 2021 | 17311 | 0.15 | Why? |
| Prescription Drugs | 1 | 2018 | 243 | 0.15 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.14 | Why? |
| Calcium Channel Blockers | 1 | 2018 | 367 | 0.14 | Why? |
| Amyloid beta-Peptides | 1 | 2016 | 185 | 0.14 | Why? |
| Follow-Up Studies | 6 | 2019 | 17020 | 0.14 | Why? |
| Sex Factors | 3 | 2021 | 11014 | 0.14 | Why? |
| Anticonvulsants | 2 | 2019 | 634 | 0.14 | Why? |
| Confidence Intervals | 1 | 2017 | 744 | 0.14 | Why? |
| Creatinine | 2 | 2018 | 1443 | 0.14 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.13 | Why? |
| Attitude to Death | 1 | 2018 | 307 | 0.13 | Why? |
| Psychotropic Drugs | 1 | 2019 | 396 | 0.13 | Why? |
| Prognosis | 7 | 2019 | 32490 | 0.13 | Why? |
| Hypotension | 1 | 2017 | 392 | 0.13 | Why? |
| Comorbidity | 6 | 2020 | 34796 | 0.13 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.13 | Why? |
| Renal Insufficiency, Chronic | 2 | 2018 | 2654 | 0.12 | Why? |
| Residence Characteristics | 3 | 2018 | 1927 | 0.12 | Why? |
| Europe | 4 | 2020 | 12702 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| Netherlands | 2 | 2018 | 3533 | 0.12 | Why? |
| Hand Strength | 1 | 2012 | 202 | 0.11 | Why? |
| Intellectual Disability | 1 | 2017 | 391 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
| Demography | 1 | 2018 | 1660 | 0.11 | Why? |
| Emergency Service, Hospital | 4 | 2019 | 14232 | 0.10 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.10 | Why? |
| Proteins | 1 | 2018 | 921 | 0.10 | Why? |
| Memory Disorders | 2 | 2017 | 190 | 0.10 | Why? |
| Hospitals, University | 2 | 2019 | 4173 | 0.10 | Why? |
| Social Class | 1 | 2018 | 1360 | 0.10 | Why? |
| Geriatrics | 1 | 2019 | 947 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2019 | 1070 | 0.09 | Why? |
| Depressive Disorder, Major | 1 | 2018 | 852 | 0.09 | Why? |
| Walking | 1 | 2012 | 442 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Urban Population | 1 | 2017 | 2000 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.08 | Why? |
| Organ Size | 2 | 2018 | 384 | 0.08 | Why? |
| Weight Loss | 1 | 2012 | 826 | 0.08 | Why? |
| Neuropsychological Tests | 2 | 2017 | 954 | 0.08 | Why? |
| Apolipoprotein E2 | 1 | 2005 | 4 | 0.08 | Why? |
| Homeless Persons | 1 | 2017 | 1171 | 0.08 | Why? |
| Informed Consent | 1 | 1993 | 890 | 0.08 | Why? |
| Angina Pectoris | 1 | 1986 | 114 | 0.08 | Why? |
| Peptide Fragments | 1 | 2016 | 2075 | 0.08 | Why? |
| Biomarkers | 6 | 2018 | 23361 | 0.08 | Why? |
| Recurrence | 1 | 2016 | 3675 | 0.07 | Why? |
| Magnetic Resonance Imaging | 3 | 2018 | 6551 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.07 | Why? |
| Kidney Function Tests | 2 | 2018 | 520 | 0.07 | Why? |
| Disease Progression | 3 | 2019 | 13580 | 0.07 | Why? |
| Practice Guidelines as Topic | 1 | 2010 | 15421 | 0.07 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.07 | Why? |
| Rural Population | 1 | 2017 | 2408 | 0.07 | Why? |
| Australia | 1 | 2018 | 6306 | 0.07 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.07 | Why? |
| Apolipoprotein E4 | 1 | 2005 | 99 | 0.07 | Why? |
| Stroke | 2 | 2005 | 8839 | 0.07 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.07 | Why? |
| Long-Term Care | 1 | 2016 | 2047 | 0.07 | Why? |
| Activities of Daily Living | 1 | 2012 | 1530 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
| Socioeconomic Factors | 2 | 2017 | 8495 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Risk Assessment | 5 | 2019 | 25439 | 0.06 | Why? |
| Patient Acceptance of Health Care | 2 | 2018 | 5002 | 0.06 | Why? |
| United Kingdom | 3 | 2021 | 18046 | 0.06 | Why? |
| Surveys and Questionnaires | 4 | 2018 | 43792 | 0.06 | Why? |
| Antidepressive Agents | 2 | 2018 | 509 | 0.06 | Why? |
| Pacemaker, Artificial | 1 | 1986 | 431 | 0.06 | Why? |
| Heart Diseases | 1 | 1999 | 3503 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Age Distribution | 3 | 2018 | 3567 | 0.05 | Why? |
| Vitamins | 2 | 2020 | 1208 | 0.05 | Why? |
| ROC Curve | 1 | 2012 | 6024 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Alleles | 1 | 2005 | 1557 | 0.05 | Why? |
| Tilt-Table Test | 1 | 2018 | 20 | 0.05 | Why? |
| Complement Factor B | 1 | 2018 | 36 | 0.05 | Why? |
| Food, Fortified | 1 | 2018 | 43 | 0.05 | Why? |
| Housing for the Elderly | 1 | 2018 | 59 | 0.05 | Why? |
| Mental Processes | 1 | 2017 | 19 | 0.05 | Why? |
| Complement Factor H | 1 | 2018 | 83 | 0.05 | Why? |
| Atrophy | 1 | 2018 | 192 | 0.04 | Why? |
| Neuronal Plasticity | 1 | 2018 | 98 | 0.04 | Why? |
| Psychosocial Deprivation | 1 | 2017 | 39 | 0.04 | Why? |
| Group Homes | 1 | 2017 | 29 | 0.04 | Why? |
| Photometry | 1 | 2017 | 2 | 0.04 | Why? |
| Macular Pigment | 1 | 2017 | 2 | 0.04 | Why? |
| Neural Pathways | 1 | 2018 | 155 | 0.04 | Why? |
| Mental Recall | 1 | 2017 | 77 | 0.04 | Why? |
| Stress, Psychological | 2 | 2018 | 10231 | 0.04 | Why? |
| Motor Skills | 1 | 2017 | 57 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| DNA Helicases | 1 | 2018 | 203 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Immunoglobulins | 1 | 1982 | 811 | 0.04 | Why? |
| Complement C3 | 1 | 2018 | 271 | 0.04 | Why? |
| European Union | 1 | 2019 | 565 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Smoking | 2 | 2018 | 3358 | 0.03 | Why? |
| Comprehension | 1 | 2017 | 259 | 0.03 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 1999 | 694 | 0.03 | Why? |
| Referral and Consultation | 1 | 2010 | 4816 | 0.03 | Why? |
| Genotype | 1 | 2005 | 4697 | 0.03 | Why? |
| Eye | 1 | 2017 | 374 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.03 | Why? |
| Syndrome | 1 | 2017 | 1310 | 0.03 | Why? |
| Population Density | 1 | 2017 | 694 | 0.03 | Why? |
| Physical Examination | 1 | 2018 | 755 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Geography | 1 | 2018 | 1801 | 0.03 | Why? |
| Affect | 1 | 2017 | 549 | 0.03 | Why? |
| Environment | 1 | 2017 | 769 | 0.03 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.03 | Why? |
| Alcoholism | 1 | 2018 | 691 | 0.03 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2017 | 1425 | 0.02 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.02 | Why? |
| Epilepsy | 1 | 1982 | 1401 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Child | 2 | 2017 | 70012 | 0.02 | Why? |
| Quality of Life | 2 | 2021 | 9820 | 0.02 | Why? |
| Equipment Design | 1 | 1999 | 3095 | 0.02 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.02 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.02 | Why? |
| Electrophysiology | 1 | 1986 | 64 | 0.02 | Why? |
| Kidney Failure, Chronic | 1 | 2003 | 3222 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Adolescent | 3 | 2017 | 86841 | 0.02 | Why? |
| Renal Dialysis | 1 | 2003 | 4358 | 0.02 | Why? |
| Life Style | 1 | 2018 | 2708 | 0.02 | Why? |
| Qualitative Research | 1 | 2017 | 4337 | 0.02 | Why? |
| Social Support | 1 | 2019 | 3183 | 0.02 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2005 | 6166 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Mental Health | 2 | 2021 | 15770 | 0.02 | Why? |
| Physician-Patient Relations | 1 | 1993 | 1266 | 0.02 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.02 | Why? |
| Adult | 4 | 2017 | 244371 | 0.01 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.01 | Why? |
| Exercise Test | 1 | 1986 | 911 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.01 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Sex Distribution | 1 | 2003 | 2083 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |